CCNE1 and ovarian cancer: MiR-424-5p inhibits CCNE1 expression (encoding cyclin E1) in ovarian cancer, and inhibits cell cycle by suppressing the E2F transcription factor 1 (E2F1)-RB transcriptional corepressor (PRb) pathway, which promotes apoptosis [41].